Related Experiment Video
Updated: Aug 6, 2026
12:52
Detection of Signaling Effector-Complexes Downstream of BMP4 Using in situ PLA, a Proximity Ligation Assay
Published on: March 3, 2011
Gbetagamma subunit combinations differentially modulate receptor and effector coupling in vivo
L Robillard1, N Ethier, M Lachance
1Centre de recherche, Institut de cardiologie de Montréal et Département d'anésthesie-réanimation, Université de Montréal 5000 rue Bélanger est, H1T 1C8, Montréal, PQ, Canada.
Cellular Signalling
|November 18, 2000
Summary
Specific Gbetagamma subunit combinations differentially modulate potassium channels (Kir 3.2) in vivo, unlike in vitro findings. Receptor type influences Gbetagamma subunit preference, impacting effector modulation by heterotrimeric G proteins.
Area of Science:
- Molecular and Cellular Biology
- Biochemistry
- Pharmacology
Background:
- Heterotrimeric G proteins mediate signal transduction from cell surface receptors to intracellular effectors.
- Gbetagamma subunits are known to interact with various downstream effectors, but their specificity in vivo is not fully understood.
- Previous in vitro studies showed limited specificity of Gbetagamma subunit combinations for effector modulation.
Purpose of the Study:
- To investigate the in vivo specificity of different Gbetagamma subunit combinations in modulating ion channel activity.
- To determine if specific Gbetagamma subunit preferences exist for different beta-adrenergic receptors (betaARs).
- To elucidate the role of Gbetagamma subunit combinations in receptor-G protein coupling and effector activation.
Main Methods:
- Coexpression of beta(1)AR and beta(2)AR with the inwardly rectifying potassium channel Kir 3.2 in Xenopus oocytes.
- Systematic testing of various Gbeta (1,5) and Ggamma (1,2,7,11) subunit combinations to assess Kir 3.2 activation.
- Measurement of receptor-stimulated GTPase activity of Gsalpha to assess G protein activation.
Main Results:
- Significant variations in Kir 3.2 channel activation were observed with different Gbetagamma subunit combinations following receptor stimulation.
- Beta(1)AR showed preference for Gbeta(5)gamma(1) and Gbeta(5)gamma(11), while beta(2)AR preferred Gbeta(1)gamma(7), Gbeta(1)gamma(11), and Gbeta(5)gamma(2).
- No specificity was observed in Gbetagamma subunit facilitation of receptor-stimulated Gsalpha GTPase activity, contrasting with Kir 3.2 modulation.
Conclusions:
- Specific Gbetagamma subunit combinations confer differential effector modulation capabilities in vivo.
- Receptor-specific interactions with Gbetagamma subunits, rather than Gbetagamma-effector interactions, dictate signaling specificity.
- The findings highlight the importance of specific heterotrimeric G protein composition in determining the functional outcome of receptor stimulation.
Related Concept Videos
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:22Activation and Inactivation of G Proteins
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...